SCHEMBL24323682

SCHEMBL24323682

C[C@@H]1CCCCN1c1cncc(C=O)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
GAA P10253 1/20 0.39
CHRM4 P08173 6/20 0.39
MAPT P10636 3/20 0.38
KDM4E B2RXH2 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
SMPD3 Q9NY59 2/20 0.38
PIM1 P11309 1/20 0.38
PIM3 Q86V86 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
LATS1 O95835 1/20 0.37
MEN1 O00255 1/20 0.35
HPGD P15428 1/20 0.35
KMT2A Q03164 1/20 0.35
LMNA P02545 3/20 0.35
TSHR P16473 2/20 0.35
HTT P42858 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29600541 1.00 ALDH1A1 (0.39) ALDH1A1SMN1; SMN2GAACHRM4MAPT
SCHEMBL24324008 0.96 SMPD3 (0.41) ALDH1A1SMN1; SMN2GAACHRM4MAPT
SCHEMBL1326312 0.78 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2GAACHRM4MAPT
SCHEMBL6214234 0.75 PDE10A (0.48) ALDH1A1SMN1; SMN2MAPTKDM4EPIM2
SCHEMBL29600540 0.74 MAPT (0.41) ALDH1A1SMN1; SMN2GAACHRM4MAPT
SCHEMBL24324092 0.74 MAPT (0.41) ALDH1A1SMN1; SMN2GAACHRM4MAPT
SCHEMBL1326991 0.74 KDM4E (0.39) ALDH1A1SMN1; SMN2GAACHRM4MAPT
SCHEMBL24269963 0.73 PDE10A (0.42) CHRM4MAPTKDM4EL3MBTL1SMPD3
SCHEMBL24269964 0.73 PDE10A (0.42) CHRM4MAPTKDM4EL3MBTL1SMPD3
SCHEMBL24323734 0.73 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2GAACHRM4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116601158-A Modulators of cystic fibrosis transmembrane conductance regulator 弗特克斯药品有限公司 2023-08-15 CN disclosed
WO-2022076622-A2 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed